Back to Search
Start Over
Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)
- Source :
- Journal of Translational Medicine, Journal of translational medicine 2015, 13:160
- Publication Year :
- 2015
-
Abstract
- Background The clinical development of advanced therapy medicinal products (ATMPs), a new class of drugs, requires initial safety studies that deviate from standard non-clinical safety protocols. The study provides a strategy to address the safety aspects of biodistribution and tumorigenicity of ATMPs under good laboratory practice (GLP) conditions avoiding cell product manipulation. Moreover, the strategy was applied on a human ATMP for cartilage repair. Methods The testing strategy addresses biodistribution and tumorigenicity using a multi-step analysis without any cell manipulation to exclude changes of test item characteristics. As a safeguard measurement for meeting regulatory expectations, the project design and goals were discussed continuously with the regulatory authority using a staggered scientific advice concept. Subsequently, the strategy was applied to co.don chondrosphere® (huChon spheroid), a tissue-engineered matrix-free ATMP of human normal chondrocytes. In both the biodistribution and tumorigenicity studies, huChon spheroids were implanted subcutaneously into 40 immunodeficient mice. Biodistribution was studied 1 month after implantation. A skin disc containing the huChon spheroid, two surrounding skin rings and selected organs were analyzed by validated, gender-specific, highly-sensitive triplex qPCR and by immunohistochemistry (IHC). Results No human DNA was detected in distant skin rings and analyzed organs. IHC revealed no direct or indirect indications of cell migration. Tumorigenicity was assessed 6 months after huChon spheroid implantation by palpation, macroscopic inspection, histology and IHC. No mice from the huChon spheroid group developed a tumor at the implantation site. In two mice, benign tumors were detected that were negative for HLA-ABC, suggesting that they were of spontaneous murine origin. Conclusions In summary, the presented strategy using a multi-step analysis was confirmed to be suitable for safety studies of ATMPs. Electronic supplementary material The online version of this article (doi:10.1186/s12967-015-0517-x) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
Quality Control
safety
chondrocytes
Mice, SCID
Mice
Mice, Inbred NOD
Animals
Humans
ddc:610
Prospective Studies
biodistribution
Medicine(all)
Tissue Engineering
Biochemistry, Genetics and Molecular Biology(all)
Research
Genetic Therapy
ATMP
Biodistribution, Tumorigenicity, Safety, ATMP, Cartilage repair, Chondrocytes
Cartilage
Karyotyping
Bioverteilung, Tumorerzeuger, Sicherheit, ATMP, Knorpelaufbau, Chondrozyten
NIH 3T3 Cells
tumorigenicity
Female
cartilage repair
Patient Safety
Caco-2 Cells
Laboratories
Neoplasm Transplantation
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Journal of Translational Medicine, Journal of translational medicine 2015, 13:160
- Accession number :
- edsair.pmid.dedup....f8de952b7077185472d5ec324ba003ed